FDA panel gives diabetes drug Avandia a limited victory
Jun 12, 2013
A Food and Drug Administration advisory panel has voted to ease measures that limit patient access to the diabetes pill Avandia.
Avandia gets FDA win, but is unlikely to dominate market again
By
Elizabeth Newman
Jun 10, 2013
A Food and Drug Administration advisory panel has voted to ease measures that limit patient access to the diabetes pill Avandia. Many panelists, however, said precautions are still needed.
GSK will pay $90 million to settle diabetes drug allegations
Nov 20, 2012
GlaxoSmithKline will pay a $90 million settlement to 38 states that claimed it unlawfully promoted its diabetes treatment Avandia (rosiglitazone). As a result of the settlement, GSK must change the way...
GSK agrees to pay $90 million to settle diabetes drug allegations
By
McKnight's Staff
Nov 19, 2012
GlaxoSmithKline will pay a $90 million settlement to 38 states that claimed it unlawfully promoted its diabetes treatment Avandia (rosiglitazone). The attorneys general of several states confirmed the...
GlaxoSmithKline will pay $3 billion to settle criminal charges
Jul 03, 2012
In what is the biggest healthcare fraud settlement in U.S. history, drug maker GlaxoSmithKline will pay $3 billion and plead guilty to illegally promoting prescription drugs
Drug company to pay $3 billion to settle criminal charges
Jul 02, 2012
In what is the biggest healthcare fraud settlement in U.S. history, drugmaker GlaxoSmithKline will pay $3 billion and plead guilty to illegally promoting prescription drugs.
FDA puts heavy restrictions on Avandia
May 20, 2011
The Food and Drug Administration announced Wednesday that it will pull Avandia from retail pharmacy shelves due to the diabetes drug’s cardiovascular threat to patients.
Popular diabetes medication linked to heart attack, death
Mar 22, 2011
A new study links the popular diabetes drug Avandia with an increased risk of heart attack and death, which could have a considerable effect on public health, according to researchers.